Skip to content
Trial Eligibility
Menu

Lung Cancer Clinical Trials near Orlando, FL

84 studies for Lung Cancer are recruiting at 114 sites within 50 miles of Orlando, Florida, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Lung Cancer trials in the US or all trials near Orlando.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Lung Cancer studies enrolling near Orlando

Showing the 50 nearest of 84 studies.
  1. Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

    NCT07222566

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Florida Cancer Specialists (Orlando, FL); Orlando Health Ambulatory Care Center (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    11 sites within 50 mi
  2. Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

    NCT07227298

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Orlando Health Ambulatory Care Center (Orlando, FL); Orlando Health Cancer Institute (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  3. Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

    NCT06357533

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Research Site (Orlando, FL); Research Site (Clermont, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  4. Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

    NCT05624996

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Orlando Health Cancer Institute (Orlando, FL); Winter Haven Hospital (Winter Haven, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  5. A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

    NCT05914116

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Research Site 137 (Orlando, FL); Research Site 118 (Celebration, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  6. A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

    NCT06131840

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Florida Cancer Specialists (Orlando, FL); Sarah Cannon Research Institute at Florida Cancer Specialists (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  7. A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

    NCT06667076

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: AdventHealth Orlando (Orlando, FL); Orlando Health Cancer Institute (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  8. A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

    NCT03526835

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Sarah Cannon Research Institute (Lake Nona) (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  9. A Study of Sigvotatug Vedotin in Advanced Solid Tumors

    NCT04389632

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Florida Cancer Specialists (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  10. The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

    NCT04585750

    • Phase 1/2
    • Ages 12 years and older
    • Sex: All

    Nearest site: Advent Health (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  11. Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

    NCT04613596

    • Phase 2/3
    • Ages 18 years and older
    • Sex: All

    Nearest site: AdventHealth Orlando (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  12. A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

    NCT04913285

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Sarah Cannon Research Institute - Florida Cancer Specialists (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  13. Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion

    NCT05245500

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Sarah Cannon Research Institute at Florida Cancer Specialists (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  14. A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

    NCT05361174

    • Phase 1/2
    • Ages 18 to 70 years
    • Sex: All

    Nearest site: Orlando Health Cancer Institute (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  15. A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

    NCT05498428

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: AdventHealth (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  16. A Study of DB-1310 in Advanced/Metastatic Solid Tumors

    NCT05785741

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Sarah Cannon Research Institute at Florida Cancer Specialists (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  17. Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

    NCT05983432

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Sara Cannon Research Institute Lake Nona (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  18. Safety and Efficacy of OBX-115 in Advanced Solid Tumors

    NCT06060613

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Orlando Health Cancer Institute (Melanoma/NSCLC) (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  19. A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

    NCT06119581

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Orlando Health Cancer Institute (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  20. A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

    NCT06150664

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Florida Cancer Specialists - Lake Nona (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  21. A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

    NCT06203210

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: AdventHealth Orlando, Cancer Institute (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  22. Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

    NCT06293898

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Sarah Cannon Research Institute - Lake Nona Florida (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  23. A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)

    NCT06362252

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Advent Health Orlando (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  24. Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier

    NCT06426628

    • Observational
    • Ages 29 to 85 years
    • Sex: All

    Nearest site: Orlando VA Healthcare System (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  25. Study of XB010 in Subjects With Solid Tumors

    NCT06545331

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Sarah Cannon Research Institute at Florida Cancer Specialists (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  26. MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

    NCT06586515

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Florida Cancer Specialists - Lake Nona - Sarah Cannon Research Institute (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  27. A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

    NCT06586957

    • Phase 1
    • Ages 19 years and older
    • Sex: All

    Nearest site: AdventHealth Cancer Institute (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  28. A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)

    NCT06667908

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Orlando Health Cancer Institute (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  29. A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

    NCT06706076

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Sarah Cancer Research Institution - Florida Cancer Specialist (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  30. Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

    NCT06765109

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: AdventHealth Cancer Institute (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  31. Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

    NCT06767514

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Clinical Study Site (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  32. A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

    NCT06793215

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Advent Health Orlando (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  33. A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

    NCT06835569

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Research Site (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  34. A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

    NCT06914128

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Sarah Cannon Research Institute at Florida Cancer Specialists- Lake Nona (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  35. A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

    NCT06999187

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Dren Investigational Site (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  36. A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

    NCT07020117

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Advent Health Medical Group Radiation Oncology at Central Florida (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  37. Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

    NCT07030257

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Florida Cancer Specialists-Lake Nona (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  38. AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

    NCT07038343

    • Phase 1/2
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Avenzo Therapeutics Recruiting Site (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  39. A Study of LY4175408 in Participants With Advanced Cancer

    NCT07046923

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Florida Cancer Specialists - Lake Nona - Sarah Cannon Research Institute (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  40. Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)

    NCT07154706

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Advent Health (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  41. A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer

    NCT07174583

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Sarah Cannon Research Institute at Florida Cancer Specialists (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  42. A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors

    NCT07181473

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Florida Cancer Specialists & Research Institute (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  43. A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)

    NCT07227597

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Orlando Health Cancer Institute ( Site 0108) (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  44. Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots

    NCT07231159

    • Observational
    • Ages 18 years and older
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: Adventhealth (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  45. A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

    NCT07277413

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Sarah Cannon Research Institute at Florida Cancer Specialists (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  46. A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

    NCT07365241

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Orlando Health Cancer Institute /ID# 280418 (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  47. Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung

    NCT07499674

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Orlando Health Cancer Center (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  48. Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)

    NCT07778316

    • Phase 3
    • Ages 18 to 99 years
    • Sex: All

    Nearest site: University of Florida Health Cancer Center at Orlando Health (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  49. Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

    NCT06122077

    • Observational
    • Ages 50 years and older
    • Sex: All

    Nearest sites: Charter Research (Winter Park, FL); I.H.S Health, LLC (Kissimmee, FL)

    Distance to nearest recruiting site
    ~5 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  50. A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

    NCT06172478

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: AdventHealth Medical Group Oncology Research at Celebration (Kissimmee, FL)

    Distance to nearest recruiting site
    ~16 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Lung Cancer clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.